Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial
Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision tag was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the previous Revision: v3.4.1.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page shows an addition of Revision: v3.4.1 and a deletion of Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedGlossary display option added and QC-related metadata updated to show Last Update Submitted that Met QC Criteria and a revision footer with v3.4.0. The older QC wording (Last Update Submitted that met QC Criteria), No FEAR Act data, and Revision: v3.3.4 text were removed.SummaryDifference0.2%

- Check86 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. No visible changes were made to study details or layout.SummaryDifference0.1%

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.